41 Quotes by Jan Wald

I think it's an amazing turn of events.

I think they (St. Jude) definitely look like they are in play. They certainly would be an attractive candidate.

I think they easily could go up to $76 without a lot of damage.

It is another indication that the processes could have been better ? but the company is working hard on it already.

I think there are some actions the company will have to take and some expenses the company will have to incur that will make it tough. I still think given those parameters, it can be, stay and remain an independent company and eventually flourish.

J&J needs something like Guidant to revitalize its growth. People are now thinking that if J&J does walk away, St. Jude is in their scopes.

J&J needs something like Guidant to revitalize its growth,

People are Guidant's most important asset, ... so there are hard trade-offs for Guidant to work through.

The problem that Johnson & Johnson and any company even half the size of Johnson & Johnson faces is buying something that can impact their growth rate, and that's not an easy task.